Corbus Pharmaceuticals (CRBP) announced the appointment of Rachelle Jacques as Chair of its Board of Directors, effective May 15. She succeeds Alan Holmer, who will remain on the Board.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals price target lowered to $28 from $40 at B. Riley
- Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
- Corbus Pharmaceuticals price target lowered to $56 from $60 at Oppenheimer
- Corbus Pharmaceuticals price target lowered to $40 from $50 at H.C. Wainwright
- Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss